Therefore, inhibition of MDH1 is considered a promising target for suppressing the glycolytic pathway, TCA cycle, T cell differentiation, and the inflammatory milieu in RA so it may be a prospective treatment target for RA disease. The gene discussed is MDH1; the disease is rheumatoid arthritis.